IR — Ingersoll Rand Inc.

Ingersoll Rand Inc. Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Q4 Performance:

  • Organic order growth: Low single-digit growth, 8% increase in total orders year-over-year.
  • Revenue: Up 10% year-over-year; organic revenue growth at 3%.
  • Adjusted EBITDA: $580 million with a margin of 27.7%.
  • Adjusted EPS: $0.96, a 14% increase year-over-year.

• Full Year 2025:

  • Total revenue: Up 6% year-over-year; organic revenue down 1% due to tough comps in the first half.
  • Adjusted EBITDA: Approximately $2.1 billion (27.4% margin).
  • Adjusted EPS: $3.34, up 2% year-over-year.
  • Cash flow for Q4: $462 million; total liquidity: $3.8 billion.
  • Capital deployment included $525 million in M&A, $1 billion in share repurchases, and $32 million in dividends.

2. Strategic Updates and Business Highlights:

• Continued momentum in recurring revenue, exceeding $450 million in 2025 with a backlog of $1.1 billion.
• M&A strategy remains robust with 16 transactions in 2025 generating approximately $275 million in annualized revenue; nine additional transactions under letter of intent (LOI) for 2026.
• Successful acquisition of Synomics in January 2026, enhancing life science capabilities.
• Strong performance in the life sciences segment, with mid-teens organic order growth in Q4.

3. Forward Guidance and Outlook:

• 2026 revenue growth expected between 2.5%-4.5%, with organic growth projected at 1% and M&A contributing 1.5%.
• Adjusted EBITDA guidance for 2026: $2.13 billion to $2.19 billion.
• Adjusted EPS forecast: $3.45 to $3.57, reflecting approximately 5% growth at the midpoint.
• Corporate costs anticipated at $170 million, evenly distributed throughout the year.

4. Bad News, Challenges, or Points of Concern:

• Organic revenue growth is expected to be flat to slightly down in Q1 2026, indicating potential deceleration.
• Margin pressure anticipated in the first half of 2026 due to tariff impacts and ongoing commercial investments.
• EMEA segment showed a mid-single-digit decline in Q4 orders, attributed to project timing rather than underlying demand issues.
• Long-cycle project decision-making remains elongated, though projects are not being canceled.
• Concerns over the sustainability of growth in certain markets, particularly aerospace and defense, which are moving sideways.

5. Notable Q&A Insights:

• Management confirmed that the guidance does not embed any significant market recovery, maintaining a cautious outlook.
• Positive indicators include improved PMI readings and strong marketing qualified leads, although decision-making delays persist.
• The recurring revenue business is expected to maintain a higher margin profile, but reinvestments are necessary for future growth.
• The company remains disciplined in capital allocation, with a focus on maintaining strong balance sheet flexibility despite rising valuations in the M&A landscape.

Overall, Ingersoll Rand Inc. demonstrated a solid performance in Q4 2025, with strategic growth initiatives in place, but faces challenges in the form of market uncertainties and margin pressures as it moves into 2026.